Investigational Site Number : 3800004

Perugia 06132

0 studies enrolling now · 2 studies all time

What they study most

Heart Failure, Malignant Melanoma, Squamous Cell Carcinoma of Skin, Type 2 Diabetes Mellitus

Studies at this site

• A Study of SAR444245 Combined With Cemiplimab for the Treatment of Participants With Various Advanced Skin Cancers (Pegathor Skin 201) — Stopped early
• Effect of Sotagliflozin on Cardiovascular Events in Participants With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial) — Stopped early